The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...

Mick Foley is getting in shape. The wrestling legend joked about entering this year’s Royal Rumble match as he updated fans on his impressive weight loss journey. The WWE legend decided last ...

The market for GLP-1 drugs is projected to exceed $200 billion in annual sales by 2031, according to Morningstar Equity Research. Current market leaders include Novo Nordisk NVO and Eli Lilly LLY with ...

There's new evidence the class of drugs that includes Ozempic may have health benefits that go beyond diabetes treatment and weight loss. A major new study suggests these drugs could help with dozens ...

Karen Huger revealed whether she's using Ozempic, explaining she's using a medication for a reason other than weight loss. Learn more.

Getting a move on can do a number on belly fat, but the key is getting physical activity almost daily. Uwazurike suggests ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

A large analysis of weight-loss drugs like Ozempic and Wegovy has surprised health researchers, who found links to multiple new benefits – and some new side effects.

Read here for a detailed financial analysis of Medifast stock post-pandemic, GLP-1 impact, and the company's collaboration ...

Millions of obese Americans have achieved successful weight loss through use of glucagon-like peptide-1 agonists (GLP-1), a game-changing class of obesity medications. Results are often dramatic, but ...